In patients with NAFLD and T2DM, hypermetabolism has a direct association with adiponectin, physical activity, ALT and diastolic blood pressure, but a diverse relationship with FFM. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.